ClinicalTrials.govpublic full text
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
nsclc, melanoma, kidney cancer, urothelial carcinoma, head and neck cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 426758
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.